PT  - JOURNAL ARTICLE
AU  - Helwick, Caroline
TI  - Milnacipran for the Treatment of Fatigue Associated with Fibromyalgia
DP  - 2010 Aug 01
TA  - MD Conference Express
PG  - 14--14
VI  - 10
IP  - 4
4099  - http://mdc.sagepub.com/content/10/4/14.1.short
4100  - http://mdc.sagepub.com/content/10/4/14.1.full
AB  - Milnacipran may be an effective treatment for the fatigue that is associated with fibromyalgia (FM). FM is a chronic disorder with symptoms, including musculoskeletal pain and allodynia, as well as debilitating fatigue. Milnacipran is a dual reuptake inhibitor of serotonin and norepinephrine that is used for the treatment of FM. This article discusses an evaluation the effect of milnacipran on fatigue in patients with FM (as determined by American College of Rheumatology criteria) in a pooled analysis of three Phase III trials.